These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 15117435
1. Composition of LDL particle discriminates between hypercholesterolaemic persons with and without symptoms of coronary heart disease. Van Jaarsveld H, Pool GF, Bester CJ. Ann Clin Biochem; 2004 May; 41(Pt 3):213-9. PubMed ID: 15117435 [Abstract] [Full Text] [Related]
3. Dietary iron elevates LDL-cholesterol and decreases plasma antioxidant levels: influence of antioxidants. Pool GF, van Jaarsveld H. Res Commun Mol Pathol Pharmacol; 1998 May; 100(2):139-50. PubMed ID: 9667068 [Abstract] [Full Text] [Related]
5. Lipid peroxidative damage in the erythrocytes and elevation of serum LDL-cholesterol, apolipoprotein-B, ferritin and uric acid with age and in coronary heart disease patients. El-Gebali HH, Tahir SA, Haider SS, El-Fakhri MM. Saudi Med J; 2000 Feb; 21(2):184-9. PubMed ID: 11533779 [Abstract] [Full Text] [Related]
6. Carbohydrate intake is correlated with biomarkers for coronary heart disease in a population of overweight premenopausal women. Lofgren IE, Herron KL, West KL, Zern TL, Patalay M, Koo SI, Fernandez ML. J Nutr Biochem; 2005 Apr; 16(4):245-50. PubMed ID: 15808329 [Abstract] [Full Text] [Related]
7. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial. Stender S, Schuster H, Barter P, Watkins C, Kallend D, MERCURY I Study Group. Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130 [Abstract] [Full Text] [Related]
8. Prevalence and particularities of dyslipidaemia in subjects with coronary heart disease. Agoşton-Coldea L, Zdrenghea D, Pop D, Crăciun A, Rusu ML, Mocan T. Rom J Intern Med; 2007 Jul; 45(4):341-7. PubMed ID: 18767409 [Abstract] [Full Text] [Related]
9. [Findings or disease--lipid metabolism with reference to the heart]. Wolfram G. Internist (Berl); 1986 Mar; 27(3):158-65. PubMed ID: 3519502 [No Abstract] [Full Text] [Related]
10. Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease. Barrios V, Amabile N, Paganelli F, Chen JW, Allen C, Johnson-Levonas AO, Massaad R, Vandormael K. Int J Clin Pract; 2005 Dec; 59(12):1377-86. PubMed ID: 16351668 [Abstract] [Full Text] [Related]
11. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study. Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group. Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694 [Abstract] [Full Text] [Related]
18. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women. El ayachi M, Mziwira M, Vincent S, Defoort C, Portugal H, Lairon D, Belahsen R. Eur J Clin Nutr; 2005 Dec; 59(12):1379-86. PubMed ID: 16118656 [Abstract] [Full Text] [Related]
19. Temporal changes in anthropometric parameters and lipid profile according to body mass index among an adult Iranian urban population. Bozorgmanesh MR, Hadaegh F, Padyab M, Mehrabi Y, Azizi F. Ann Nutr Metab; 2008 Dec; 53(1):13-22. PubMed ID: 18772585 [Abstract] [Full Text] [Related]